Humane Genomics
Engineered viruses to defeat cancer
New York, New York, United States
Humane Genomics focuses on engineering viruses to selectively kill cancer cells.
Problem Statement
Cancer treatments often lack the specificity to target and eliminate malignant cells without harming healthy tissue.
Core Technology
engineering viruses to selectively kill cancer cells
Key Differentiators
Engineering viruses to selectively target and kill cancer cells
Clinical Focus
Oncology
Company Info
- Founded
- 2017
- Website
- humanegenomics.com/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
In vivo mouse models demonstrate safety profile and 50% tumor volume reduction. Lead candidate entering GMP manufacturing (Genezen partnership, Nov 2025). Preclinical path to IND application underway.
Only accessible to MedStartr community members.
Join nowWhat do you think of Humane Genomics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.